Atheln is a contract development team supporting biopharma companies and investors in all phases of development and across all major classes and therapeutic areas. Atheln integrates technical, regulatory, and commercial needs to mitigate risk and maximize client success. Expertise includes nonclinical, CMC, quality, regulatory, clinical, product strategy, business development, and market access/reimbursement.
Adriana Manzi Managing Director Email: [email protected] Phone: 858-554-0636
Monica Alfaro Welling Managing Director Email: [email protected] Phone: 310-220-4332www.athelnbiomed.com 6051 Scripps Street San Diego, CA 92122 USA